Alexandria Real Estate Equities
ARE
#2256
Rank
โ‚ฌ7.65 B
Marketcap
44,50ย โ‚ฌ
Share price
-1.36%
Change (1 day)
-36.41%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

EPS for Alexandria Real Estate Equities (ARE)

EPS in 2026 (TTM): -5,31ย โ‚ฌ

According to Alexandria Real Estate Equities 's latest financial reports the company's current EPS (TTM) is -5,41ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -7,28ย โ‚ฌ.

EPS history for Alexandria Real Estate Equities from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-5,31ย โ‚ฌ-27.1%
2025-7,28ย โ‚ฌ
20222,70ย โ‚ฌ-17.41%
20213,27ย โ‚ฌ-35.32%
20205,06ย โ‚ฌ89.03%
20192,68ย โ‚ฌ-12.68%
20183,06ย โ‚ฌ
20140,87ย โ‚ฌ-36.87%
20131,38ย โ‚ฌ46.79%
20120,94ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,13ย โ‚ฌ-120.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
24,36ย โ‚ฌ-550.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
12,50ย โ‚ฌ-330.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6,40ย โ‚ฌ-218.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
4,77ย โ‚ฌ-188.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
3,07ย โ‚ฌ-156.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
3,27ย โ‚ฌ-160.45%๐Ÿ‡บ๐Ÿ‡ธ USA